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Summary
Background  and  objectives:  The  diagnosis  of  granulomatous  inﬂammation  with  pos-
sible  tuberculosis  (TB)  infection  in  histopathology  is  often  difﬁcult.  There  is  a  need
for  a  rapid  and  reliable  diagnostic  test.  Thus,  we  evaluated  the  performance  of
the  Mycobacterium  tuberculosis  direct  (MTD)  test  in  specimens  with  granulomatous
lymphadenitis  and  negative  acid  fast  stains.
Methods:  The  M.  tuberculosis  direct  (MTD)  test  by  Gen-Probe  was  performed  on
45  formalin-ﬁxed  parafﬁn-embedded  tissue  samples  including  34  lymph  nodes.  We
measured  the  predictive  values  of  the  MTD  test  in  specimens  with  granulomatous
lymphadenitis  and  negative  acid  fast  stains.
Results:  The  overall  test  sensitivity  was  73.9%,  and  speciﬁcity  was  95.4%.  The  MTD
test  sensitivity  and  speciﬁcity  for  lymph  node  tissue  were  72.7%  and  91.67%,  respec-
tively.  In  the  presence  of  granulomatous  inﬂammation,  the  MTD  test  sensitivity
and  speciﬁcity  were  higher  than  those  for  all  tissue  samples,  at  75%  and  100%,
respectively.∗ Corresponding author at: P.O. Box 76, Building 62, Room: 296-C, Saudi Aramco, Dhahran 31311, Saudi Arabia.
el.: +966 503 855 208; fax: +966 13 877 6783.
E-mail address: wasim.raslan@aramco.com (W.F. Raslan).
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Conclusion:  Based  on  this  study,  the  MTD  test  should  be  used  as  a  supportive  test
in  addition  to  conventional  histochemical  or  immunological  staining  methods  when
evaluating  lymph  node  tissue  with  a  granulomatous  inﬂammation  to  deliver  stronger
ical  decisions  at  a  much  earlier  time  than  a  culture  would
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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Germany).  We  followed  the  manufacturer’s  instruc-
tions but  used  double  volumes  for  all  reagents  toevidence  to  support  clin
allow.
©  2014  King  Saud  Bin  Ab
Ltd.  All  rights  reserved.
Introduction
The  diagnosis  of  granulomatous  inﬂammation  with
possible tuberculosis  (TB)  infection  in  histopatho-
logy is  often  frustrating  for  the  treating  physician
and pathologist.  The  pathologist  cannot  ascertain
that granulomas  with  caseous  necrosis  are  caused
by TB  infection  unless  they  demonstrate  acid  fast
bacilli (AFB).  As  a  result,  clinicians  often  have  to
wait for  another  six  to  eight  weeks  before  they  can
receive  conﬁrmatory  culture  results.  The  treatment
decision is  often  made  based  upon  clinical  suspicion
and the  knowledge  that  such  a  diagnosis  cannot  be
ignored. The  challenge  is  that  most  patients  with
extrapulmonary  TB  have  little  or  no  symptoms  and
are considered  a  low-suspicion  group.  There  is  a
real need  for  a  rapid  and  reliable  diagnostic  test
to allow  the  pathologist  to  give  an  evidence-based
diagnosis to  the  treating  physician  when  granulo-
mas are  encountered  in  asymptomatic  patients.
Several authors  have  demonstrated  a consistent
ability to  identify  Mycobacterium  tuberculosis  com-
plex (MTC)  in  formalin-ﬁxed  parafﬁn-embedded
(FFPE)  tissue,  with  variable  sensitivity  [1—3].  How-
ever, none  of  the  published  reports  measured  the
predictive  value  of  these  tests  in  light  of  a  low
clinical suspicion  level  and  negative  special  histo-
chemical  stains.
This study  simulates  the  frequently  encountered
scenario of  granulomatous  inﬂammation  with  low
clinical suspicion  for  TB  infection  and  negative  acid
fast stain  (AFS).  Most  of  the  tissue  selected  was
from lymph  node  biopsies  because  it  represents  the
most frequently  encountered  specimen  from  those
patients  in  our  population  [4].
This study  measures  the  predictive  value  of
applying molecular  methods  such  as  the  M.  tubercu-
losis direct  (MTD)  test  by  Gen-Probe  to  detect  MTC
in extracted  nucleic  acids  from  FFPE  tissue.  In  addi-
tion to  lymph  nodes,  the  sensitivity  and  speciﬁcity
of this  technique  were  also  measured  for  differ-
ent tissue  types  against  the  results  of  fresh  tissue
culture as  the  gold  standard.  The  patient’s  clini-
cal probability  level  was  evaluated  as  low  clinical
suspicion by  a  qualiﬁed  infection  disease  specialist.
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caterials and methods
he  ﬁles  of  Saudi  Aramco  Medical  Services  Organi-
ation were  searched  for  cases  that  had  TB  culture
erformed on  the  same  fresh  biopsy  tissue  from
atients with  low  clinical  suspicion  for  TB.  Low
linical suspicion  was  deﬁned  as  no  systemic  symp-
oms of  fever,  night  sweats,  anorexia  or  weight
oss. Patient  symptoms  included  cervical  lymph
denopathy,  abnormal  chest  X-ray,  one  case  of  brain
esion and  one  case  of  osteomyelitis.  A  total  of
5 cases  were  selected,  and  23  cases  had  gran-
lomatous inﬂammatory  reaction  and  a negative
eel-Nelson histochemical  special  stain.  Seventy
ve percent  of  the  cases  were  from  lymph  node
iopsy specimens  (34/45  cases).  The  reference
ulture methods  used  included  the  liquid-based
ycobacteria growth  indicator  tube  (MGIT)  culture
ystem,  conventional  solid  Löwenstein—Jensen  (LJ)
edium and  Middlebrook  medium.
The removal  of  the  tissue  from  the  parafﬁn
as performed  as  described  by  Wright  et  al.  with
odiﬁcations  [5]. Three  35-m-thick  sections  of
FPE tissue  were  placed  in  1.5-ml  Eppendorf  tubes.
o avoid  cross-contamination,  a new  microtome
lade was  changed  after  sectioning  each  sample.
eparafﬁnization of  the  sample  was  performed
y adding  1  ml  of  xylene,  followed  by  vortexing
or 1  min  at  room  temperature  and  centrifuging
t 16,000  ×  g  for  10  min;  the  xylene  was  then
emoved. This  step  was  repeated  at  least  twice
r until  the  wax  was  completely  dissolved.  The
emaining  xylene  was  washed  off  by  adding  1  ml  of
bsolute alcohol  with  vortexing  for  20  s  and  cen-
rifugation at  16,000  ×  g  for  10  min.  The  ethanol
as then  removed.  This  last  step  was  repeated
wice, and  the  tubes  were  left  open  to  dry.
The nucleic  acid  was  extracted  following  QIAamp
ini DNA  kit  instructions  (Qiagen  GmBH,  Hilden,atch the  high  amount  of  tissue  used.  In  addition,
he elution  volume  was  increased  to  300  l using
CR-grade water  for  10  min  or  more.  The  DNA  con-
entration  was  then  measured  using  an  Ependorf
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tredictive  value  of  Gen-Probe’s  ampliﬁed  MTD  test  
iophotometer.  The  lowest  DNA  concentration  level
chieved  in  positive  cases  was  13  g/ml.
The detection  of  MTC  was  performed  according
o instructions  of  the  ampliﬁed  M.  tuberculo-
is direct  (MTD)  (Gen-Probe,  San  Diego,  CA)
anufacturer’s package  insert,  as  follows.  All  reac-
ion volumes  were  brought  to  a  total  level  of
50 l for  the  test  sample  and  the  controls  using
ALC/NaOH/phosphate  buffer  solution.  To  achieve
hat, a total  of  200  l  of  the  eluted  nucleic
cid sample  was  transferred  to  250  l  of  the
ALC/NaOH/phosphate  buffer  solution.  To  monitor
ny inhibitory  effect,  100  l  of  the  eluted  sample
as transferred  to  a  new  tube  containing  300  l
f NALC/NaOH/phosphate  buffer  solution  and  was
piked with  50  l  of  M.  tuberculosis  positive  con-
rol. The  remaining  detection  and  reporting  steps
ollowed  the  Gen-Probe  manufacturer’s  instruc-
ions.
esults
he  distribution  of  the  45  tissue  samples  was  as  fol-
ows: 34  lymph  nodes,  six  biopsies  from  the  lung  and
leura, and  ﬁve  cases  from  soft  tissue,  bone  and
rain and  meninges  (see  Table  1).  Granulomatous
nﬂammation  was  detected  in  23  of  the  45  cases.
wenty-two of  the  34  lymph  nodes  showed  granulo-
atous  lymphadenitis  (64.7%).  The  total  number  of
s
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Table  1  Distribution  of  tissue  samples  with  Gen-Probe  (MT
Tissue  type Total  Culture  Pos.
MTD  Pos.
Cultu
MTD  
Lymph  node  34  16  6  
Lung  and  pleura  6  1  0  
Other  tissue  5  0  0  
Total  N  =  45  (100%)  17  6  
aMTD, Mycobacterium tuberculosis direct test by Gen-Probe; POS.,
Table  2  Predictive  values  of  MTD  test  in  the  presence  or  a
Total  Culture
Pos.
MTDa Pos.
Culture
Pos.
MTDa Neg.
Culture
Neg.
MTDa Pos.
Granulomas  23  15  5  0  
No  granulomas  22  2  1  1  
All  tissue  45  17  6  1  
a Mycobacterium tuberculosis direct test.
b Sensitivity.
c Speciﬁcity.
d Positive predictive value.
e Negative predictive value.253
ositive  cases  by  the  MTD  test  was  18  out  of  45  cases
40%). One  of  the  18  cases  showed  equivocal  results
wice  and  was  considered  positive  according  to  the
anufacturer  recommendation.  This  was  a lymph
ode  tissue  with  no  granulomas  (Table  2).  Because
he culture  was  negative,  this  case  was  considered  a
alse-positive  case.  This  was  the  only  false-positive
ase out  of  the  total  45  cases  (2.2%).  Thus,  17  of
he 45  cases  were  positive  by  both  the  culture  and
TD test  (37.7%).  The  cases  that  were  negative
y both  MTD  and  culture  were  considered  as  the
egative  control  group.  This  included  21  samples
46.6%). Three  out  of  the  21  negative  control  cases
howed  granulomatous  inﬂammation  (Table  2).  Two
f the  three  cases  were  lymph  node  samples  and
he patients  were  considered  as  a  possible  sarcoido-
is or  atypical  TB  infection  and  improved  with  anti
B treatment.  The  third  case  was  that  of  a 73-
ear-old male  smoker  who  was  diagnosed  with  right
pper lobe  pneumonia  and  improved  with  antibi-
tics treatment.  The  false  negative  group  included
ix out  of  45  cases  that  were  positive  by  culture  and
egative by  MTD  test  (13.3%)  (Table  1).
Considering  the  culture  results  as  a  gold  standard
nd with  no  regard  to  the  presence  of  granulomas,
he Gen-Probe  method  on  all  the  selected  cases
howed  a  detection  sensitivity  of  73.9%  and  a speci-
city of  95.4%.  Accordingly,  the  positive  predictive
alue was  94.4%,  and  the  negative  predictive  value
as 77.7%  (see  Table  2).
D)  and  culture  results.
re  Pos.
Neg.
Culture  Neg.
MTD  Pos.
Culture  Neg.
MTD  Neg.
1  11
0  5
0  5
1  21
 positive; Neg., negative.
bsence  of  granulomas  against  tissue  culture.
Culture
Neg.
MTDa Neg.
Senb Spec PPVd NPVe
3  75% 100%  100%  37.5%
18  66.67%  94.74%  66.67%  94.74%
21  73.9%  95.4%  94.4%  77.78%
254  W.F.  Raslan  et  al.
Table  3  Predictive  values  of  MTD  test  and  culture  results  in  lymph  node  tissue  with  and  without  granulomas.
Total  Culture
Pos.
MTDa Pos.
Culture
Pos.
MTDa Neg.
Culture
Neg.
MTDa Pos.
Culture
Neg.
MTDa Neg.
Senb Spec PPVe NPVf
LNd with
granuloma
22 14  5  1  2  73.68  66.67  93.3  28.57
LNd with  no
granuloma
12  2  0  0  10  100  100  100  100
Total  LNd
cases
34 16  5  1  2  72.73  91.67  94.12  64.71
a Mycobacterium tuberculosis direct test.
b Sensitivity.
c Speciﬁcity.
d Lymph node.
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bPositive predictive value.
f Negative predictive value.
When  a  sub-analysis  was  performed  to  compare
the MTD  test  predictive  values  between  cases  with
granulomas  and  all  cases,  the  group  with  granu-
lomas showed  a  slightly  increased  sensitivity  and
speciﬁcity  and  positive  predictive  value;  however,
the negative  predictive  value  became  remarkably
lower (37.5%).  This  is  caused  by  the  low  number
of cases  that  had  granulomatous  inﬂammation  and
negative culture  (Table  2).
The test  predictive  values  for  all  lymph  node  tis-
sue showed  high  sensitivity  and  speciﬁcity  of  72.73%
and 91.67%,  respectively.  However,  the  speciﬁcity
of the  test  decreased  to  66.67%  when  we  limited
the analysis  to  only  lymph  node  cases  with  granulo-
matous inﬂammation  (see  Table  3).
Discussion
The  low  suspicion  of  tuberculosis  continues  to  be
a major  challenge,  with  the  diagnosis  of  granulo-
matous inﬂammation  often  being  the  ﬁrst  medical
evidence  for  TB  infection.  At  least  15%  of  TB  infec-
tion occurs  in  extrapulmonary  sites  [6].  It  has  been
reported  by  Small  et  al.  in  a  large  retrospective
study that  30%  of  the  HIV  population  has  only  extra-
pulmonary  TB  infection  [7].  In  a  previous  study
from our  institution,  extrapulmonary  tuberculosis
constituted 51%  of  all  culture-positive  tuberculosis,
and most  cases  presented  with  lymphadenopathy
[4].  Unfortunately,  histopathologists  continue  to
insist on  visualizing  the  TB  organism  in  situ  with
the help  of  special  immunological  or  histochemical
stains to  conﬁrm  TB  infection,  despite  the  low
sensitivity of  these  methods.  Consequently,  many
false negative  results  are  issued,  leading  to  delayed
diagnosis  and  treatment.  The  reported  contributing
o
d
t
iactors  to  this  low  sensitivity  include  a  number  of
rganisms  in  tissue  sections  below  the  required
04—106 organisms  per  milliliter  and  the  anti-TB
reatment effect  on  the  bacterial  cell  wall  [8,9].
Under  such  circumstances,  the  laboratory  fails
o deliver  the  needed  conclusive  evidence  at  a  very
ritical time  in  patient  management.  This  labora-
ory evidence  is  needed  to  treat  patients  promptly
r to  prevent  the  administration  of  inappropriate
reatment, such  as  steroids  to  patients  with  medi-
stinal lymphadenopathy.  Due  to  the  high  negative
redictive  value  of  this  test,  clinicians  will  have
he option  in  low-suspicion  cases  to  safely  delay
mpiric  anti-TB  treatment  during  the  eight-week
eriod until  the  culture  results  are  ﬁnalized.  This
ill lead  to  signiﬁcant  treatment  cost  savings  and
ill prevent  the  harm  of  unnecessary  anti-TB  med-
cation.  In  addition,  early  and  adequate  treatment
ill reduce  the  patient’s  risk  from  progressing  to
eneralized  disease  or  developing  multi-drug  resis-
ant TB  infection.  There  is a  clinical  need  for  a
iagnostic  test  that  is  faster  than  culturing  and  has
trong predictive  values.  Such  a test  is needed  to
upport  early  treatment  decisions  when  granulo-
as are  unexpectedly  encountered  in  low-suspicion
ases with  negative  AFS.  The  cases  selected  for
his study  simulated  this  frequently  encountered,
ifﬁcult scenario  and  focused  on  cases  with  granu-
omatous  lymphadenitis.
Although  rapid  molecular  detection  methods  for
B are  now  highly  standardized  and  automated,
hey are  often  limited  to  a speciﬁed  specimen
ype and  collection  techniques  to  avoid  PCR  inhi-
ition or  to  overcome  the  low  number  of  TB
rganisms [10—12]. However,  many  authors  have
emonstrated  the  reproducibility  of  applying  these
echniques  on  FFPE  tissue,  with  variable  sensitiv-
ty [1—3]. Manzano  et  al.  compared  the  sensitivity
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hredictive  value  of  Gen-Probe’s  ampliﬁed  MTD  test  
nd  speciﬁcity  of  the  Gen-Probe  MTD  test  and  LCx
TB test  by  Abbott  [2]. They  reported  sensitivities
f 52%  and  67%,  respectively,  and  the  speciﬁcity
or both  tests  was  100%.  This  is in  line  with  our
verall sensitivity  of  73.9%  and  speciﬁcity  of  95.4%.
espite  the  reported  difﬁculties  in  applying  molec-
lar techniques  on  FFPE  tissue,  recent  nucleic  acid
xtraction  methods,  such  as  that  described  by  Qia-
en, have  signiﬁcantly  improved  the  quality  of  the
xtracted  nucleic  acid  material  almost  to  the  level
f fresh  frozen  tissue  [13].
Lymph nodes  represented  most  of  the  specimens
n this  study  (75%),  which  reﬂected  the  nature  of
he clinical  presentation  of  lymphadenopathy  in  our
atient population  of  extra  pulmonary  tuberculosis
ases [4].  Cases  from  other  tissues  were  included
o explore  the  possible  effect  of  tissue  type  on  the
redictive  values  in  comparison  to  lymph  nodes.
As expected,  the  predictive  values  of  the  MTD
est on  lymph  nodes  with  granulomatous  inﬂamma-
ion were  of  equal  sensitivity  (73.68%)  to  overall
issue samples  (73.9%)  because  most  of  the  posi-
ive cases  were  from  lymph  nodes.  However,  the
peciﬁcity  of  the  MTD  test  on  granulomatous  lym-
hadenitis  was  lower  than  the  total  number  of  cases
ue to  the  low  number  of  cases  with  negative  cul-
ure in  this  group  (see  Table  3).
The predictive  values  of  non-lymph  node  tis-
ue were  not  reliable  due  to  the  low  number  of
ases with  positive  results.  This  is  expected  because
ymph  nodes  act  as  bacterial  ﬁlters,  which  results  in
 higher  number  of  bacterial  loads  in  the  specimen.
he Gen-Probe  MTD  test  was  chosen  for  this  study
ecause  of  its  higher  sensitivity,  whereby  more  than
000 copies  of  ribosomal  RNA  are  produced  per  cell
ather than  per  target  sequence  [2,14,15].  Because
f its  increased  sensitivity,  this  test  method  was
mong  the  ﬁrst  tests  approved  by  the  Food  and  Drug
dministration  (FDA)  for  smear-negative  sputum
esting,  with  a  calculated  sensitivity  of  41—48%.
he test  sensitivity  and  speciﬁcity  in  our  study  were
ound to  be  higher  than  those  reported  by  Man-
ano et  al.  when  using  the  same  MTD  molecular
est on  FFPE  tissue  [2]. The  possible  contribut-
ng factors,  in  addition  to  a  high  percentage  of
ymph node  tissue  samples,  include  using  three
5-m-thick sections  compared  to  two  10-U-thick
ections. In  addition,  we  used  double  volumes  from
ll extraction  reagents,  which  resulted  in  higher
ucleic  acid  concentration.  Our  result  conﬁrmed
he conclusion  of  Marchetti  et  al.,  who  listed  DNA
oncentration  among  the  factors  that  must  be  con-
rolled in  detecting  TB  in  FFPE.  In  addition,  these
uthors  listed  adequate  numbers  of  the  MTB  orga-
isms  and  an  adequate  target  DNA  size  [1].  By
sing  culture  results  as  a  gold  standard,  we  also
m
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emonstrated  that  the  granulomatous  reaction  did
ncrease the  MTD  test  sensitivity.  However,  when
he sub-analysis  was  limited  to  the  granuloma-
ositive group,  the  speciﬁcity  and  the  negative
redictive value  decreased.  This  was  caused  by  the
ow number  of  cases  that  had  negative  culture  in
he presence  of  granulomatous  inﬂammation.
Our  ﬁndings  are  also  consistent  with  those
eported by  Vlaspolder  et  al.  for  fresh  sputum  sam-
les and  Lo  et  al.  for  FFPE  tissue—–culturing  is  a
etter test  than  MTD  in  ruling  out  MTC  infection  in
xtrapulmonary  disease  [15,16]. A  feasible  expla-
ation is  related  to  the  rare  false-positive  results
or the  MTD  test  due  to  its  ability  to  detect  non-
iable organisms  that  cannot  be  cultured.  However,
n our  study,  we  came  across  this  scenario  only  in
ne case  where  the  MTD  test  was  positive  and  the
ulture  was  negative.  Aggarwal  et  al.  reported  the
dvantage  of  using  the  MTD  test  in  addition  to  tissue
ulture and  conventional  tests  as  a rapid  method  to
valuate synovial  ﬂuid  and  rule  out  TB  arthritis  prior
o surgery  [17].
In  addition,  under  these  conditions,  the  73.9%
ensitivity of  the  MDT  test  is  higher  than  the
ensitivities reported  for  histochemical  or immuno-
istological  stains,  47.09%  and  59.35%,  respectively.
his  is  statistically  signiﬁcant  because  the  margin  of
rror in  our  study  and  those  reported  by  Grang  et  al.
nd Whily  et  al.  are  less  than  0.05%  [8,9].
As a  result  of  this  investigation,  we  recommend
hat conventional  histochemical  or  immunological
taining methods  should  be  supplemented  by  the
TD test  when  evaluating  lymph  node  tissue  with
 granulomatous  inﬂammation  to  deliver  stronger
vidence to  support  the  clinical  decision.  Prior  to
ccepting  a  case  for  analysis,  a  minimum  DNA  con-
entration  level  of  13  m/ml  should  be  achieved,
nd the  pathologist  should  ensure  the  presence
f granulomatous  inﬂammation.  In  addition,  the
esults should  be  reported  with  a note  highlight-
ng the  test  predictive  values  for  the  tissue  type
nder these  conditions.  More  comparative  studies
etween  molecular  techniques  on  FFPE  tissue  and
ulture methods  are  needed  to  identify  the  most
redictive  test.  These  studies  should  take  into  con-
ideration  the  effect  of  tissue  type  on  the  test
ensitivity due  to  the  variability  in  bacterial  load.
In conclusion,  the  Gen-Probe  test  method  for
FPE lymph  node  tissue  is  a reliable  and  repro-
ucible one.  It  has  stronger  predictive  values  to
etect MTB  organisms  than  those  reported  for
istochemical  and  immunohistochemical  staining
ethods.  This  test  should  be  used  in  addition  to
mmunoperoxidase  and  histochemical  staining  to
rovide strong  evidence  to  the  treating  physician
t an  earlier  time  when  dealing  with  unexpected
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granulomatous  lymphadenitis  in  low-suspicion  TB
patients.
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